Insulet Corp (PODD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

100 NAGOG PARK ACTON, MA 01720

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

Data as of 2021-08-02 07:36:53 -0400
Market Cap18.535 Billion Shares Outstanding66.271 Million Avg 30-day Volume318.542 Thousand
P/E Ratio2082.62963 Dividend Yield EPS0.133
Price/Sales19.33 Debt to Equity3.14 EBITDA119.6 Million
Price to Book Value31.67 Forward PE0.94 Enterprise Value18.753 Billion
Total Cash850.2 Million Current Debt185.5 Million Gross Profit622.9 Million
BETA1.25953 52-week High/Low306.46 / 192.98 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PODD instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 7 7 0.0% 8 (0.47%) 7 (0.41%) 14.29%
Funds Holding: 437 454 -3.74% 116 (6.81%) 128 (7.43%) -9.38%
13F shares: 68.883 Million 68.522 Million 0.53% 16.753 Million 16.04 Million 4.45%
% Ownership 25.4113 24.329 4.45%
New Positions: 46 73 -36.99% 13 25 -48.0%
Increased Positions 162 160 1.25% 46 48 -4.17%
Closed Positions 57 37 54.05% 22 14 57.14%
Reduced Positions 167 163 2.45% 50 44 13.64%
Total Calls 143.463 Thousand 323.408 Thousand -55.64% 8.7 Thousand 18 Thousand -51.67%
Total Puts 403.516 Thousand 111.403 Thousand 262.21% 22.5 Thousand 62.6 Thousand -64.06%
PUT/CALL Ratio 2.81 0.34 726.47% 2.59 3.48 -25.57%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PODD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PODD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

17.3 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

15 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ALPUCHE CHARLES EVP & CHIEF OPERATING OFFICER

  • Officer
45,527 2021-07-01 7

CRAWFORD SALLY

  • Director
20,306 2021-06-04 2

BUDDEN LAUREN VP, CAO AND CONTROLLER

  • Officer
3,816 2021-06-03 4

MANEA DAN SVP, CHIEF HR OFFICER

  • Officer
2,869 2021-06-01 2

SCANNELL TIMOTHY J

  • Director
24,387 2021-05-27 1

HOPFIELD JESSICA

  • Director
23,685 2021-05-27 1

LEMOINE DAVID A

  • Director
7,785 2021-05-27 2

MINOGUE MICHAEL R

  • Director
8,921 2021-05-27 1

NEVINNY CORINNE H

  • Director
4,158 2021-05-27 2

HOLLINGSHEAD JAMES

  • Director
3,870 2021-05-27 1

FREDERICK WAYNE A.I.

  • Director
1,824 2021-05-27 3

FALLON JOHN A.

  • Director
14,498 2021-05-21 3

PETROVIC SHACEY PRESIDENT AND CEO

  • Officer
  • Director
152,299 2021-05-14 10

KAPPLES JOHN W. SVP, SECRETARY AND GC

  • Officer
10,172 2021-04-01 3

SPEARS MICHAEL P SVP, RA AND COMPLIANCE

  • Officer
11,062 2021-02-26 5

CHRISTENSEN BRET EVP AND CCO

  • Officer
16,259 2021-02-26 5

BENJAMIN ERIC SVP, INNOVATION AND STRATEGY

  • Officer
10,974 2021-02-26 4

MCMILLAN WAYDE D. EVP, CFO

  • Officer
21,933 2021-02-26 3

COLLERAN DAVID SVP, SECRETARY AND GC

  • Officer
30,433 2019-04-02 0

ABDEL-MALEK AIMAN EVP & CHIEF TECHNOLOGY OFFICER

  • Officer
19,687 2019-03-28 0

LEVITZ MICHAEL L SVP AND CFO

  • Officer
56,651 2019-02-27 0

MULLEN JAMES C

  • Director
7,783 2018-05-16 0

SULLIVAN PATRICK J CEO AND CHAIRMAN OF THE BOARD

  • Officer
  • Director
351,088 2018-03-29 0

THOMAS BRADLEY A EVP HUMAN RESOURCES

  • Officer
65,818 2018-03-29 0

ZAKRZEWSKI JOSEPH S

  • Director
30,558 2017-05-17 0

SOMMER REGINA O

  • Director
23,039 2017-05-17 0

LEVANGIE DANIEL J EVP & PRESIDENT, DRUG DELIVERY

  • Officer
21,122 2016-04-30 0

SOBIESKI STEVEN

  • Director
16,039 2015-05-13 0

DIEHL R ANTHONY SECRETARY AND GENERAL COUNSEL

  • Officer
40,854 2015-05-11 0

RYAN PATRICK CHIEF OPERATING OFFICER

  • Officer
47,990 2015-05-05 0

LIAMOS CHARLES T

  • Director
87,575 2015-04-01 0

DORVAL ALLISON CHIEF FINANCIAL OFFICER

  • Officer
37,415 2015-04-01 0

HAYES KATHLEEN VICE PRESIDENT, HR

  • Officer
22,346 2014-09-19 0

DESISTO DUANE PRESIDENT AND CEO

  • Officer
  • Director
257,184 2014-09-02 0

DEVLIN PETER CHIEF COMMERCIAL OFFICER

  • Officer
67,354 2014-06-09 0

ROBERTS BRIAN K CHIEF FINANCIAL OFFICER

  • Officer
120,050 2014-04-01 0

WIELINSKI TRACEY HAAS VP, GLOBAL REGULATORY, CA, QA

  • Officer
24,000 2014-03-06 0

LORTZ W MARK

  • Director
4,000 2013-06-03 0

DEPIETRO RUTHANN VICE PRESIDENT OF QUALITY

  • Officer
18,351 2012-09-04 0

JAFFE ROSS A MD

  • Director
296,810 2012-02-17 0

BOESS CARSTEN VICE PRESIDENT, INTERNATIONAL

  • Officer
18,941 2011-04-25 0

MALAVE LUIS CHIEF OPERATING OFFICER

  • Officer
195,857 2010-03-01 0

CAMPBELL ROBERT VICE PRESIDENT FOR CLINICAL

  • Officer
63,633 2010-01-25 0

EICHHORN GARY

  • Director
70,749 2009-04-20 0

BOESGAARD LARS VICE PRESIDENT OF FINANCE

  • Officer
0 2009-02-26 0

GVAZDAUSKAS SHAWNA SENIOR VICE PRESIDENT OF SALES

  • Officer
0 2009-02-26 0

SCHMID KEVIN VP OF OPERATIONS & ENGINEERING

  • Officer
0 2009-02-26 0

NG JASON VICE PRESIDENT OF ASIAN OPERAT

  • Officer
0 2009-02-26 0

GARIBOTTO JOHN VICE PRESIDENT OF RESEARCH

  • Officer
0 2009-02-26 0

ARTHUR WILLIAM D III V.P. OF BUSINESS DEVELOPMENT

  • Officer
0 2009-02-26 0

HOWE DAVID A VP OF HUMAN RESOURCES

  • Officer
0 2009-02-26 0

PEYROMAURE DE BORD ALISON

  • Director
0 2008-05-08 0

SUCHOFF ANDREW CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2008-03-27 0

SMITH JEFFEREY VICE PRESIDENT OF MARKETING

  • Officer
0 2008-03-12 0

PRISM VENTURE PARTNERS III A LP

PRISM INVESTMENT PARTNERS III LP

PRISM VENTURE PARTNERS III LLC

SEIFERT WILLIAM M

  • 10% Owner
1,200 2008-02-05 0

PRISM VENTURE PARTNERS III LP

  • 10% Owner
0 2008-02-05 0

NYE GORDON E

  • Director
0 2007-05-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PETROVIC SHACEY - Director - Officer PRESIDENT AND CEO

2021-07-02 16:08:43 -0400 2021-07-01 M 15,000 $30.58 a 30,779 direct -0.952 -6.2594 0.0 1 -6.2594 6

PETROVIC SHACEY - Director - Officer PRESIDENT AND CEO

2021-07-02 16:08:43 -0400 2021-07-01 M 15,000 d 7,436 direct

PETROVIC SHACEY - Director - Officer PRESIDENT AND CEO

2021-07-02 16:08:43 -0400 2021-07-01 S 15,000 $278.56 d 15,779 direct -0.952 -6.2594 0.0 1 -6.2594 6

ALPUCHE CHARLES - Officer EVP & CHIEF OPERATING OFFICER

2021-07-02 16:11:01 -0400 2021-07-01 S 2,250 $278.67 d 45,527 direct -0.952 -6.2594 0.0 1 -6.2594 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INSULET CORP PODD 2021-08-04 22:15:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 21:45:04 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 21:15:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 20:45:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 20:15:04 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 19:45:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 19:15:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 18:45:04 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 18:15:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 17:45:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 17:15:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 16:45:04 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 16:15:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 15:45:02 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 15:15:04 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 14:45:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 14:15:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 13:45:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 13:15:03 UTC -0.17 0.25 600000
INSULET CORP PODD 2021-08-04 12:45:03 UTC -0.17 0.25 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund PODD -14.0 shares, $-3312.26 2020-09-30 N-PORT
Jackson Variable Series Trust- JNL/Nicholas Convertible Arbitrage Fund PODD -4750.0 shares, $-786980.0 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund PODD -593.0 shares, $-97803.49 2019-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund PODD -238.0 shares, $-62098.96 2021-03-31 N-PORT
Leuthold Funds Inc- Leuthold Global Fund PODD -14.0 shares, $-3652.88 2021-03-31 N-PORT
Leuthold Funds Inc- Leuthold Core Investment Fund PODD -845.0 shares, $-220477.4 2021-03-31 N-PORT
Leuthold Funds Inc- Grizzly Short Fund PODD -2915.0 shares, $-760581.8 2021-03-31 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund PODD -655.0 shares, $-170902.6 2021-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund PODD -740.0 shares, $-193080.8 2021-03-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund PODD -704.0 shares, $-183687.68 2021-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund PODD -759.0 shares, $-198038.28 2021-03-31 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund PODD -379.0 shares, $-111888.38 2021-04-30 N-PORT
Principal Funds, Inc- Global Multi-Strategy Fund PODD 291.0 shares, $-78473.97 2021-05-31 N-PORT
GMO TRUST- GMO Alternative Allocation Fund PODD -2000.0 shares, $-539340.0 2021-05-31 N-PORT
GMO TRUST- GMO Strategic Opportunities Allocation Fund PODD -2000.0 shares, $-539340.0 2021-05-31 N-PORT
GMO TRUST- GMO Implementation Fund PODD -35200.0 shares, $-9492384.0 2021-05-31 N-PORT
GMO TRUST- GMO Benchmark-Free Fund PODD -12300.0 shares, $-3316941.0 2021-05-31 N-PORT

Elevate your investments